Latest Updates
Genetic testing education could accelerate its potential
Dr Aideen McInerey-Leo finds public has low level of understanding of genetic testing.
Skin cancer treatment aims to help transplant patients
A new medication could help prevent organ transplant recipients from developing harmful skin cancers.
An Australian-first initiative of 'bench to bedside' medical research
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.
What is Translational Research?
Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.
The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.
At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.
What's On
TRI Seminar Series
The TRI Seminar Series follows a monthly format and hosts guest speakers nominated by our partner institutes.
Cancer Seminar Series
The Cancer Seminar Series showcases research from our TRI partner institutes- UQ Diamantina, QUT and the Mater and...
Medical Grand Rounds
Medical Grand Rounds are held every Monday and can be viewed via video conference.
